Biodesix, Inc. Common Stock (BDSX) is a publicly traded Healthcare sector company. As of September 20, 2026, BDSX trades at $30.55 with a market cap of $308.09M and a P/E ratio of -9.86. BDSX moved +1.35% today. Year to date, BDSX is +329.41%; over the trailing twelve months it is +333.88%. Its 52-week range spans $3.44 to $31.31. Analyst consensus is strong buy with an average price target of $32.80. Rallies surfaces BDSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BDSX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $30.55 |
| Market Cap | $308.09M |
| P/E Ratio | -9.86 |
| EPS | $-3.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.31 |
| 52-Week Low | $3.44 |
| Volume | 75.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $102.94M |
| Net Income | $-27.76M |
| Gross Margin | 0.00% |
6 analysts cover BDSX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.80.